tiprankstipranks
Trending News
More News >
SynAct Pharma AB (DE:8F8)
FRANKFURT:8F8
Germany Market

SynAct Pharma AB (8F8) Cash flow

Compare
0 Followers

SynAct Pharma AB Cash Flow

DE:8F8's free cash flow for Q4 2024 was kr-17.78M. For the 2024 fiscal year, DE:8F8's free cash flow was decreased by kr17.38M and operating cash flow was kr-17.78M. See a summary of the company’s cash flow.
Cash Flow
Dec 23Dec 22Dec 21Dec 20Dec 19
Operating Cash Flow
kr -100.18Mkr -117.56Mkr -65.00Mkr -33.24Mkr -16.12M
Investing Cash Flow
kr 370.00Kkr 27.00Kkr -6.00Kkr -93.00Kkr -499.00K
Financing Cash Flow
kr 53.98Mkr 200.71Mkr 74.32Mkr 44.72Mkr 13.00M
End Cash Position
kr 62.40Mkr 108.25Mkr 24.00Mkr 14.55Mkr 3.56M
Free Cash Flow
kr -100.18Mkr -117.56Mkr -65.00Mkr -33.24Mkr -16.62M
Currency in SEK

SynAct Pharma AB Cash Flow

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis